Kitov Pharma (KTOV)

0.83 -0.03 (3.49%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form 6-K Kitov Pharma Ltd. For: May 16 May 16, 2019 7:32 AM - SEC Filing Form 6-K Kitov Pharma Ltd. For: May 10 May 10, 2019 4:04 PM - SEC Filing Kitov Receives Notice of Allowance for Additional U.S. Patent Covering its Commercial Product Consensiā„¢ May 10, 2019 9:20 AM - Globe NewsWire Form 6-K Kitov Pharma Ltd. For: May 09 May 9, 2019 4:09 PM - SEC Filing Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference May 9, 2019 8:30 AM - Globe NewsWire Kitov Pharma (KTOV) Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack May 2, 2019 5:26 PM - StreetInsider Form 6-K Kitov Pharma Ltd. For: May 02 May 2, 2019 4:47 PM - SEC Filing Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack May 2, 2019 4:45 PM - Globe NewsWire Form 6-K Kitov Pharma Ltd. For: Apr 29 April 29, 2019 4:32 PM - SEC Filing Form 6-K Kitov Pharma Ltd. For: Apr 15 April 15, 2019 7:22 AM - SEC Filing Form 6-K Kitov Pharma Ltd. For: Apr 12 April 12, 2019 4:05 PM - SEC Filing Kitov Announces Key Milestone in FameWave Acquisition April 12, 2019 8:28 AM - Globe NewsWire FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolu April 12, 2019 7:49 AM - Globe NewsWire Form 6-K Kitov Pharma Ltd. For: Apr 08 April 8, 2019 6:40 AM - SEC Filing Form 20-F/A Kitov Pharma Ltd. For: Dec 31 April 3, 2019 7:39 AM - SEC Filing Form 6-K Kitov Pharma Ltd. For: Apr 01 April 1, 2019 6:48 AM - SEC Filing Form S-8 Kitov Pharma Ltd. March 28, 2019 5:21 PM - SEC Filing Form 20-F Kitov Pharma Ltd. For: Dec 31 March 26, 2019 5:07 PM - SEC Filing Form 6-K Kitov Pharma Ltd. For: Mar 22 March 22, 2019 4:33 PM - SEC Filing Full Article List